ATE457726T1 - Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen - Google Patents

Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen

Info

Publication number
ATE457726T1
ATE457726T1 AT03760967T AT03760967T ATE457726T1 AT E457726 T1 ATE457726 T1 AT E457726T1 AT 03760967 T AT03760967 T AT 03760967T AT 03760967 T AT03760967 T AT 03760967T AT E457726 T1 ATE457726 T1 AT E457726T1
Authority
AT
Austria
Prior art keywords
composition
organisms
dietary
increase
pharmaceutical compositions
Prior art date
Application number
AT03760967T
Other languages
English (en)
Inventor
Robert Hageman
George Verlaan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE457726T1 publication Critical patent/ATE457726T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03760967T 2002-06-19 2003-06-19 Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen ATE457726T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077434 2002-06-19
PCT/NL2003/000448 WO2004000297A1 (en) 2002-06-19 2003-06-19 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms

Publications (1)

Publication Number Publication Date
ATE457726T1 true ATE457726T1 (de) 2010-03-15

Family

ID=29797210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03760967T ATE457726T1 (de) 2002-06-19 2003-06-19 Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen

Country Status (7)

Country Link
US (1) US20050287204A1 (de)
EP (1) EP1536781B1 (de)
AT (1) ATE457726T1 (de)
AU (1) AU2003247224A1 (de)
DE (1) DE60331319D1 (de)
ES (1) ES2341538T3 (de)
WO (1) WO2004000297A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US7850987B2 (en) 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
US20050226906A1 (en) * 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US7785619B2 (en) 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
KR101230977B1 (ko) 2004-06-09 2013-02-07 알즈켐 아게 동물 식품 첨가제로서 이용되는 구아니디노 아세트산
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
DE102005009990A1 (de) * 2005-03-04 2006-09-07 Degussa Ag Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
EP1909601B1 (de) * 2005-08-02 2013-05-22 AlzChem Trostberg GmbH Flüssig-formulierung auf basis einer guanidinoessigsäure-komponente
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
DE102006009373A1 (de) * 2006-03-01 2007-09-06 Degussa Gmbh Fertigfutter für Haustiere
DE102007004781A1 (de) * 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US8173181B2 (en) * 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
AU2012340563B2 (en) 2011-11-21 2017-01-19 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
EP3016531A4 (de) 2013-07-01 2017-05-10 The Trustees Of Princeton University Nahrungszusätze und zusammensetzung zur krebsbehandlung
WO2015120299A1 (en) * 2014-02-07 2015-08-13 University Of Utah Research Foundation Combination of creatine, an omega-3 fatty acid, and citicoline
US11504413B2 (en) 2017-03-03 2022-11-22 Exerkine Corporation Multi-nutrient composition
KR102022118B1 (ko) * 2019-01-07 2019-09-18 주식회사 아스트로젠 중추신경계 질환의 예방 또는 치료용 세린 유도체 화합물
WO2021035060A1 (en) * 2019-08-21 2021-02-25 Brain Chemistry Labs Compositions comprising a metal and l-serine, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB696405A (en) * 1950-12-15 1953-08-26 California Inst Res Found Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the same
US2761807A (en) * 1955-05-16 1956-09-04 California Inst Res Found Glycocyamine and methylating agent in vivo creatine producing composition
FR2218883B1 (de) * 1973-02-28 1976-08-13 Science Union & Cie
US4582807A (en) * 1982-07-30 1986-04-15 Natteri Veeraraghavan Cultivation medium for mycobacteria and use thereof
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
US6727285B1 (en) * 1995-11-07 2004-04-27 George M. Haik, Jr. Use of D-arginine and/or L-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
EP0891719A1 (de) * 1997-07-14 1999-01-20 N.V. Nutricia Narungszusammensetzungen mit Gehalt an Methionin
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6172114B1 (en) * 1999-09-30 2001-01-09 Worldwide Sports Nutritional Supplements, Inc. Creatine supplement

Also Published As

Publication number Publication date
US20050287204A1 (en) 2005-12-29
EP1536781A1 (de) 2005-06-08
AU2003247224A1 (en) 2004-01-06
WO2004000297A1 (en) 2003-12-31
EP1536781B1 (de) 2010-02-17
ES2341538T3 (es) 2010-06-22
DE60331319D1 (de) 2010-04-01

Similar Documents

Publication Publication Date Title
ATE457726T1 (de) Nahrungs- oder pharmazeutische zusammensetzungen zur erhöhung der creatin-antwort von organismen
WO2002071874A3 (en) Composition improving age-related physiological deficits and increasing longevity
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
DE60301491D1 (en) Acc-hemmer
BR9910296A (pt) Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
ECSP045154A (es) Composiciones de fórmula para infantes que comrende cantidades aumentadas de alfa - lactalbumin
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
TR200202175T1 (tr) Hücrelerin biyoenerji metabolizmasında bulunan biyokimyasal bileşiklerin kompozisyonları
MY166631A (en) Orally administrable composition for improving skin quality
MY133969A (en) Indoloquinazolinones
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0417093A (pt) composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal
TW200605786A (en) Dermally applicable liquid formulations for controlling parasitic arthropods on animals
BR0316782A (pt) Produto de leite fermentado, processo para preparação de um produto de leite fermentado e uso da linhagem cnrz 244 de lactobacillus helveticus
ITRM20010445A1 (it) Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
BRPI0418726A (pt) naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
EP1572086A4 (de) Verfahren und zusammensetzung auf basis der entdeckung des stoffwechsels von nitroglycerin
IL160850A0 (en) Sphingolipids
WO2005092362A3 (de) Pharmazeutisches kombinationspräparat enthaltend ein therapeutisches protein
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
PT1399142E (pt) Utilizacao de acetil-l-carnitina em associacao com biotina para o tratamento de doentes com diabetes mellitus insulino-resistente do tipo 2
MXPA03003799A (es) Composiciones solidas apropiadas para la administracion oral que contienen sales no higroscopicas de l-carnitina y l-carnitinas de alcanoilo con cloruro de taurina y cloruro de glicina.
AU2002357999A1 (en) Regulation of the accelerator concentration in phosphating baths

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties